A total of 6 and seven CRC-related expression genes were found to be significantly correlated with mTOR and HIF1-α, respectively, in the mTOR signaling pathway (Table 2), indicating that mTOR signaling is an important part of the mechanisms underlying the effects of ezetimibe against CRC. This evidence concerns the gene HIF1A and colorectal carcinoma.